J.A. Reise

537 total citations
11 papers, 365 citations indexed

About

J.A. Reise is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, J.A. Reise has authored 11 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in J.A. Reise's work include Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Breast Cancer Treatment Studies (2 papers). J.A. Reise is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Breast Cancer Treatment Studies (2 papers). J.A. Reise collaborates with scholars based in United Kingdom, Cyprus and Italy. J.A. Reise's co-authors include Roger M. Greenhalgh, P.A. Gaines, Li Gao, Louise Brown, J. J. F. Belch, Janet T. Powell, Suneil Ramessur, Keith G. Jones, Trevor A. Bayston and R. Charles Coombes and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

J.A. Reise

11 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Reise United Kingdom 8 197 145 101 80 78 11 365
Tae Jung Kwon South Korea 11 55 0.3× 155 1.1× 76 0.8× 47 0.6× 171 2.2× 28 430
M Nardi Italy 9 148 0.8× 148 1.0× 71 0.7× 25 0.3× 42 0.5× 38 370
Felicitas Lenz Germany 6 161 0.8× 135 0.9× 196 1.9× 37 0.5× 24 0.3× 8 421
A. Kommareddy United States 6 78 0.4× 54 0.4× 146 1.4× 89 1.1× 28 0.4× 6 352
Ulf Lundstam Sweden 10 34 0.2× 167 1.2× 87 0.9× 100 1.3× 88 1.1× 15 465
K. Syrigos Greece 8 157 0.8× 105 0.7× 119 1.2× 34 0.4× 24 0.3× 18 294
George A. Degenshein United States 10 99 0.5× 123 0.8× 139 1.4× 83 1.0× 26 0.3× 17 415
Roger S. Blumenthal United States 7 25 0.1× 90 0.6× 43 0.4× 34 0.4× 71 0.9× 15 400
Stephen Jones Australia 6 54 0.3× 265 1.8× 21 0.2× 36 0.5× 84 1.1× 11 386

Countries citing papers authored by J.A. Reise

Since Specialization
Citations

This map shows the geographic impact of J.A. Reise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Reise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Reise more than expected).

Fields of papers citing papers by J.A. Reise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Reise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Reise. The network helps show where J.A. Reise may publish in the future.

Co-authorship network of co-authors of J.A. Reise

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Reise. A scholar is included among the top collaborators of J.A. Reise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Reise. J.A. Reise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Stebbing, Justin, Rachel Payne, J.A. Reise, et al.. (2013). The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study. PLoS ONE. 8(5). e62543–e62543. 24 indexed citations
2.
Coombes, R. Charles, Tri Tat, J.A. Reise, et al.. (2012). An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study). Annals of Oncology. 24(4). 924–930. 14 indexed citations
3.
Bliss, Judith M., Lucy Kilburn, Robert E. Coleman, et al.. (2011). Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study. Journal of Clinical Oncology. 30(7). 709–717. 83 indexed citations
4.
Coombes, R. Charles, Judith M. Bliss, Marc Espié, et al.. (2011). Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer. Journal of Clinical Oncology. 29(24). 3247–3254. 12 indexed citations
5.
6.
Coombes, R. Charles, Judith M. Bliss, Marc Espié, et al.. (2010). DEVA: Randomized trial of sequential epirubicin and docetaxel versus epirubicin alone in node-positive postmenopausal early breast cancer (EBC) patients.. Journal of Clinical Oncology. 28(15_suppl). 536–536. 1 indexed citations
7.
Reise, J.A., H. Sheldon, J J Earnshaw, et al.. (2009). Patient Preference for Surgical Method of Abdominal Aortic Aneurysm Repair: Postal Survey. European Journal of Vascular and Endovascular Surgery. 39(1). 55–61. 45 indexed citations
8.
9.
Dick, Florian, L.C. Brown, Janet T. Powell, J.A. Reise, & Roger M. Greenhalgh. (2008). Appraisal Era for Endovascular Repair of Abdominal Aortic Aneurysms. Acta chirurgica Belgica. 108(3). 288–291. 4 indexed citations
10.
Bayston, Trevor A., Suneil Ramessur, J.A. Reise, Keith G. Jones, & Janet T. Powell. (2003). Prostaglandin e2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. Journal of Vascular Surgery. 38(2). 354–359. 48 indexed citations
11.
Reise, J.A., et al.. (1997). Glutathione and neonatal lung disease. Clinica Chimica Acta. 265(1). 113–119. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tae Jung Kwon Breakdown of academic impact, for papers by M Nardi Breakdown of academic impact, for papers by Felicitas Lenz Breakdown of academic impact, for papers by A. Kommareddy Breakdown of academic impact, for papers by Ulf Lundstam Breakdown of academic impact, for papers by K. Syrigos Breakdown of academic impact, for papers by George A. Degenshein Breakdown of academic impact, for papers by Roger S. Blumenthal Breakdown of academic impact, for papers by Stephen Jones
Rankless by CCL
2026